| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, U.s. Business Unit
1 company
Rhonda Janice Pacheco is President, U.s. Business Unit at TKPHF. Rhonda Janice Pacheco's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.7M at current prices.
The TKPHF filings lean toward selling, a net 16,901 shares.
Rhonda Janice Pacheco has 2 Form 4 filings on record from July 2026 to August 2026, all as President, U.s. Business Unit at Takeda Pharmaceutical (TKPHF), 2026.
The 2 reported transactions were 1 open-market sale and 1 stock award.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $289K.
The only open-market sale was 16,901 shares of TKPHF at an average $17.10 on August 10, 2026, about $289K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | President, U.s. Business Unit | Sell | 16,901 | $17.10 | $289,007.10 | -8.5% |